TOVX
Theriva Biologics·AMEX
--
--(--)
--
--(--)
TOVX Filings
Filing Date
Form Description
Form Type
2026-01-12
Form 8-K - Current report
Key Events
2026-01-12 · Key Events
Form 8-K - Current report
2026-01-06
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2026-01-06 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2026-01-06
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2026-01-06 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2026-01-06
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2026-01-06 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2026-01-06
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
2026-01-06 · Ownership
Form 4 - Statement of changes in beneficial ownership of securities
2026-01-05
Form DEF 14A - Other definitive proxy statements
Key Events
2026-01-05 · Key Events
Form DEF 14A - Other definitive proxy statements
2025-12-29
Form 8-K - Current report
Key Events
2025-12-29 · Key Events
Form 8-K - Current report
2025-12-23
Form PRE 14A - Other preliminary proxy statements
Key Events
2025-12-23 · Key Events
Form PRE 14A - Other preliminary proxy statements
2025-12-15
Form 8-K - Current report
Key Events
2025-12-15 · Key Events
Form 8-K - Current report
2025-12-03
Form 424B5 - Prospectus [Rule 424(b)(5)]
2025-12-03 ·
Form 424B5 - Prospectus [Rule 424(b)(5)]
